Intelligent Medicine Z Score vs. Cash Flow From Operations

IQMDWDelisted Stock  USD 0  0.00  0.00%   
Based on the measurements of profitability obtained from Intelligent Medicine's financial statements, Intelligent Medicine Acquisition may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Intelligent Medicine's ability to earn profits and add value for shareholders.
For Intelligent Medicine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Intelligent Medicine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Intelligent Medicine Acquisition utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Intelligent Medicine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Intelligent Medicine Acquisition over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Please note, there is a significant difference between Intelligent Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intelligent Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intelligent Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Intelligent Medicine Cash Flow From Operations vs. Z Score Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Intelligent Medicine's current stock value. Our valuation model uses many indicators to compare Intelligent Medicine value to that of its competitors to determine the firm's financial worth.
Intelligent Medicine Acquisition is currently regarded as number one stock in z score category among its peers. It also is currently regarded as number one stock in cash flow from operations category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Intelligent Medicine by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Intelligent Cash Flow From Operations vs. Z Score

Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Intelligent Medicine

Z Score

 = 

Sum Of

5 Factors

 = 
-0.3
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Intelligent Medicine

Operating Cash Flow

 = 

EBITDA

-

Taxes

 = 
(866.9 K)
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.

Intelligent Cash Flow From Operations Comparison

Intelligent Medicine is currently under evaluation in cash flow from operations category among its peers.

Intelligent Medicine Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Intelligent Medicine, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Intelligent Medicine will eventually generate negative long term returns. The profitability progress is the general direction of Intelligent Medicine's change in net profit over the period of time. It can combine multiple indicators of Intelligent Medicine, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Intelligent Medicine Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2021 and is based in Bethesda, Maryland. Intelligent Medicine is traded on NASDAQ Exchange in the United States.

Intelligent Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Intelligent Medicine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Intelligent Medicine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Intelligent Medicine's important profitability drivers and their relationship over time.

Use Intelligent Medicine in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Intelligent Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intelligent Medicine will appreciate offsetting losses from the drop in the long position's value.

Intelligent Medicine Pair Trading

Intelligent Medicine Acquisition Pair Trading Analysis

The ability to find closely correlated positions to Intelligent Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Intelligent Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Intelligent Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Intelligent Medicine Acquisition to buy it.
The correlation of Intelligent Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Intelligent Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Intelligent Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Intelligent Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Intelligent Medicine position

In addition to having Intelligent Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumer Staples ETFs Thematic Idea Now

Consumer Staples ETFs
Consumer Staples ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Staples ETFs theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Staples ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Consideration for investing in Intelligent Stock

If you are still planning to invest in Intelligent Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intelligent Medicine's history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance